Related content

Mycophenolate mofetil for non-renal manifestations of systemic lupus erythematosus: a systematic review

By Mok C. C.  

Scandinavian Journal of Rheumatology, Vol. 36, Iss. 5, 2007-01 ,pp. : 329-337

Informa Healthcare

Access to resources Recommend Favorite

Intercellular adhesion molecules in systemic lupus erythematosus patients with lupus nephritis

By Sabry Alaa   Sheashaa Hussein   El-Husseini Amr   El-Dahshan Khaled   Abdel-Rahim Mona   Elbasyouni Sherief  

Clinical Rheumatology, Vol. 26, Iss. 11, 2007-11 ,pp. : 1819-1823

Springer Publishing Company

Access to resources Recommend Favorite

Low-dose epoprostenol improved pulmonary hypertension in a patient with systemic lupus erythematosus

By Matsukawa Yoshihiro   Igei Kohmei   Nozaki Takamasa   Ohki Takafumi   Shimizu Takako   Kitamura Noboru   Mitamura Ko   Takei Masami   Kasamaki Yuji   Sawada Shigemasa  

Clinical Rheumatology, Vol. 26, Iss. 4, 2007-04 ,pp. : 582-583

Springer Publishing Company

Access to resources Recommend Favorite

The effectiveness and safety of mycophenolate mofetil in lupus nephritis

By Elyan Mazen   Ballou Stanley  

Clinical Rheumatology, Vol. 28, Iss. 7, 2009-07 ,pp. : 835-840

Springer Publishing Company

Access to resources Recommend Favorite

Prospective study of low-dose cyclosporine A in patients with refractory lupus nephritis

By Ogawa Hiroe   Kameda Hideto   Nagasawa Hayato   Sekiguchi Naoya   Takei Hirofumi   Tsuzaka Kensei   Amano Koichi   Takeuchi Tsutomu  

Modern Rheumatology, Vol. 17, Iss. 2, 2007-04 ,pp. : 92-97

Springer Publishing Company

Access to resources Recommend Favorite